openPR Logo
Press release

Glioma Treatment Market to Grow to $6.4 Billion by 2028 Driven by Rise in Brain and CNS Tumor Incidence

04-26-2024 04:43 PM CET | Health & Medicine

Press release from: The Business Research Company

Glioma Treatment Market Report

Glioma Treatment Market Report

The glioma treatment market size has grown strongly in recent years. It will grow from $4.7 billion in 2023 to $5.03 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to risen incidence of gliomas, advancements in molecular understanding, evolution of standard therapies, clinical trials and research progress, improved imaging and diagnostic techniques.

The glioma treatment market size is expected to see strong growth in the next few years. It will grow to $6.4 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to personalized therapies and biomarker discovery, immunotherapeutic advancements, integration of targeted therapies, emergence of novel therapeutic platforms, collaborative research initiatives. Major trends in the forecast period include blood-brain barrier penetrating agents, liquid biopsy for monitoring, focus on quality of life and supportive care, genetic and molecular subtyping, patient advocacy and involvement.

Market Overview -
Glioma treatment refers to a treatment that reduces symptoms, removes and control the tumor and limits long-term damage to the brain or spinal cord. They are used to kills any glioma cells that might remain after surgery.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10689&type=smp

Glioma Treatment Market Driven By The Surge In Brain And Cns Tumor Incidence
The rise in brain and CNS tumor incidence is expected to propel the growth of the glioma treatment market going forward. Brain and spinal cord tumors are uncontrolled masses of abnormal brain or central nervous systems. Glioma treatment is used in brain and spinal cord cancer to destroy any remaining cancer cells or parts of the tumor after surgery. For instance, in August 2021, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, it is estimated that 24,530 malignant tumors and 59,040 nonmalignant tumors will be identified with brain and other CNS cancers in the United States in 2021, accounting for 83,570 cases, and 18,600 deaths from the disease. Therefore, the rise in the incidence of brain and spinal cord tumors is driving the growth of the glioma treatment market.

Competitive Landscape -
Major companies operating in the glioma treatment market report are Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Thermo Fisher Scientific Inc., Emcure Pharmaceuticals Ltd., Sigma-Aldrich Co., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.

Daiichi Sankyo Introduces Innovative Glioma Treatment With Launch Of The World's First Oncolytic Virus Therapy For Brain Cancer
Product innovation is a key trend gaining popularity in the glioma treatment market. Major companies operating in the glioma treatment market are adopting new innovative products to sustain their position in the market. For instance, in November 2021, Daiichi Sankyo Company Limited, a Japan-based pharmaceutical company, launched Delytact, a cancer-fighting virus and the world's first oncolytic virus therapy for brain cancer. Its viral genome carries three triple mutations that enhance and selectively replicate in cancer cells and aid in treating malignant glioma.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report

Key Segments -
The glioma treatment market covered in this report is segmented -
1) By Type: Low-Grade, High-Grade
2) By Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Other Treatments
5) By End-User: Hospitals, Specialty Clinics, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glioma Treatment Market to Grow to $6.4 Billion by 2028 Driven by Rise in Brain and CNS Tumor Incidence here

News-ID: 3477886 • Views:

More Releases from The Business Research Company

Well Testing Services Market to Reach$10.54 Billion by 2028, Fueled by Global Oil Demand Surge
Well Testing Services Market to Reach$10.54 Billion by 2028, Fueled by Global Oi …
The well testing services market size has grown strongly in recent years. It will grow from $7.78 billion in 2023 to $8.27 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to global energy demand, exploration and production activities, reservoir management, asset integrity management, multi-well testing campaigns, rise in deepwater and ultra-deepwater exploration. The well testing services market size
Strong Growth Expected in Well Intervention Market, Reaching $12.06 Billion by 2028
Strong Growth Expected in Well Intervention Market, Reaching $12.06 Billion by 2 …
The well intervention market size has grown strongly in recent years. It will grow from $8.93 billion in 2023 to $9.47 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to reservoir management and optimization, economic viability, production enhancement, regulatory compliance, emergency response and well control, maturing oil and gas fields. The well intervention market size is expected to
Well Completion Equipment Market to Reach $14.19 Billion by 2028, Fueled by Oil Demand
Well Completion Equipment Market to Reach $14.19 Billion by 2028, Fueled by Oil …
The well completion equipment and services market size has grown strongly in recent years. It will grow from $9.93 billion in 2023 to $10.67 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to oil demand, hydraulic fracturing revolution, deepwater exploration, market volatility, geopolitical factors. The well completion equipment and services market size is expected to see strong growth
Well Cementing Services Market to Reach $14.92 Billion by 2028, Fueled by Industry Consolidation
Well Cementing Services Market to Reach $14.92 Billion by 2028, Fueled by Indust …
The well cementing services market size has grown strongly in recent years. It will grow from $10.32 billion in 2023 to $11.13 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to industry consolidation and market dynamics, standardization and quality control, safety and risk mitigation, geopolitical and economic facto, training and skilled workforce development. The well cementing services market

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications